Navigation Links
Senokot(R) Tablets Undergo a Natural Makeover

STAMFORD, Conn., Aug. 6 /PRNewswire/ -- The Purdue Products L.P. line of laxatives unveiled its newest addition on June 28, at the National Association of Chain Drug Stores (NACDS) 2009 Marketplace Conference, in Boston. Newly reformulated Senokot(R) Tablets are not chemically processed, and the primary ingredient is the deseeded pod of the senna plant.

(Photo: )

"We've always been proud of the fact that Senokot(R) Tablets are such a trusted laxative brand," says Charlene Bailey, Director, Product Management, Purdue Products L.P. "But we're really excited to give consumers something new - especially at a time when interest is so high in natural products." The new Senokot(R) Tablets will be available in pharmacies (drug, food and mass merchandisers) nationwide in October 2009.

Purdue will support the introduction with a comprehensive media plan that includes national television advertising, retail account programs, coupons, and rebates. In addition, the contemporary design for the brand will not only stand out on-shelf, but will also reinforce Senokot(R) and Senokot-S(R) Tablets as a natural choice for today's health-minded consumers.

With more than four million Americans reporting that they suffer from frequent constipation(1), this common digestive health complaint can be attributed to many causes. Stress, poor diet and lack of exercise can all take a toll on the body. The new, reformulated Senokot(R) and Senokot-S(R) Tablets provide an effective option that pharmacists and other healthcare professionals can feel good about recommending to consumers to treat occasional constipation associated with diet or lifestyle.

The new Senokot(R) and Senokot-S(R) Tablets will be hitting the shelves in the fall, joining the other Purdue Laxative brands, including Colace (R) Capsules and Peri-Colace(R) Tablets and rounding out the company's comprehensive offerings for relief for occasional constipation.

The Purdue Products L.P. Line of Laxatives

Senokot(R) Tablets and Colace(R) Capsules have been recommended by doctors and pharmacists for more than 50 years for effective, gentle and safe relief from occasional constipation. Colace(R) Capsules, the #1 recommended stool softener brand by doctors and pharmacists, relieves occasional constipation that may be associated with certain medical conditions. Senokot (R)Tablets provide gentle, yet effective relief for occasional constipation associated with diet or lifestyle. The Purdue laxative portfolio includes: Colace(R) Capsules, Peri-Colace(R) Tablets, Senokot(R) Tablets, Senokot-S(R) Tablets and SenokotXTRA(R) Tablets. The Purdue laxative portfolio is dedicated to providing consumers with specific solutions to the various types of occasional constipation that can occur as a part of everyday life.

(1) National Institute of Diabetes and Digestive and Kidney Diseases. (2007). National Digestive Diseases Information Clearing House: Constipation. Retrieved January 26, 2009, from

    Press Contact:
    Vicky Toporovsky
    Pollock Communications

SOURCE Purdue Products L.P.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. Actavis Launches Carvedilol Tablets in the U.S.
3. Mylan Announces Final FDA Approval for Carvedilol Tablets
4. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
5. Actavis Launches Amlodipine Tablets in the U.S.
6. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
7. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
8. KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
9. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
10. Ranbaxy Receives Tentative Approval For Valsartan Tablets
11. Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Post Your Comments:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... in America. As people age, more care is needed, especially with Alzheimer’s, dementia ... medical professionals are being overworked. The forgotten part of this equation: 80 percent ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, ... from Hillside, N.J. "Many people catch diseases simply from sitting on such dirty ... be protected from germs." , He developed the patent-pending QUDRATECS to eliminate the ...
(Date:11/27/2015)... ... 27, 2015 , ... ProSidebar: Fashion is a set of 30 ... ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX production. ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... 25, 2015 ... the "Global Brain Monitoring Devices Market ... --> ) has announced the ... Devices Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/25/2015)... 25, 2015  The American Academy of Pediatrics ... and the March of Dimes cheered today,s signature ... Infants Act of 2015 (S.799), which takes ... born exposed to drugs, such as opioids, and ... all three organizations have worked together leading advocacy ...
Breaking Medicine Technology: